Serum Concentrations of Antimycobacterial Drugs in Patients with Pulmonary Tuberculosis in Botswana
Open Access
- 15 August 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (4) , 461-469
Abstract
Background. We conducted a pharmacokinetic study of antimycobacterial drugs involving a cohort of patients with pulmonary tuberculosis (TB) in GaboroKeywords
This publication has 27 references indexed in Scilit:
- Association between Acquired Rifamycin Resistance and the Pharmacokinetics of Rifabutin and Isoniazid among Patients with HIV and TuberculosisClinical Infectious Diseases, 2005
- The Clinical Pharmacokinetics of Pyrazinamide in HIV‐Infected Persons with TuberculosisClinical Infectious Diseases, 2004
- Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspectiveArchives of internal medicine (1960), 1997
- Pulmonary Tuberculosis in HIV-Infected Patients in Zaire — A Controlled Trial of Treatment for Either 6 or 12 MonthsNew England Journal of Medicine, 1995
- Drug Malabsorption and Resistant Tuberculosis in HIV-Infected PatientsNew England Journal of Medicine, 1995
- Malabsorption of Antimycobacterial MedicationsNew England Journal of Medicine, 1993
- Increased recurrence of tuberculosis in HIV-1-infected patients in KenyaThe Lancet, 1993
- Malabsorption of Antituberculosis Medications by a Patient with AIDSNew England Journal of Medicine, 1992
- Increased Mortality and Tuberculosis Treatment Failure Rate among Human Immunodeficiency Virus (HIV) Seropositive Compared with HIV Seronegative Patients with Pulmonary Tuberculosis Treated with “Standard” Chemotherapy in Kinshasa, ZaireAmerican Review of Respiratory Disease, 1991
- The use of pyrazinamide plus isoniazid in the treatment of pulmonary tuberculosisTubercle, 1959